TABLE 2.
Dosing and costs of various CLAD treatments.
| Treatment | Typical CLAD regimen | Costs* | Notes |
|---|---|---|---|
| Azithromycin | 250 mg orally 3×/week or 250 mg every other day | € | Generic; very low cost across EU. Often <€10 for a month’s supply |
| Montelukast | 10 mg orally daily | € | Generic; inexpensive in most EU countries |
| Pirfenidone | 801 mg 3×/day (standard dose) | €€ | Generic; widely available. Actual reimbursed costs vary |
| ECP | Initial: 2 days every 1–2 weeks; Maintenance: 2 days every 4 weeks** | €€€ | Varying availability. Highly variable by center, frequency, and technology (online vs. offline). Reimbursement differs by country |
| ATG | Short course (3–10 doses, total 3–9 mg/kg) | €€€ | Varying availability. Vial costs vary; total depends on weight and protocol |
| Alemtuzumab | Usually 1–few 10–30 mg IV doses | €€€ | Varying availability |
Monthly costs in Europe € - < 100€, €€ 100–1.000€, €€€ = >1.000€.
Differing schedules exist.
ATG, anti-thymocyte globulin; CLAD, chronic lung allograft dysfunction; ECP, extracorporeal photopheresis.